CompletedNot Applicable

An Observational Clinical Study of the T3 Dental Implant System

United States, Germany139 participantsStarted 2021-10-20

Plain-language summary

This will be a prospective, observational study where all implants will be placed in either the maxilla or mandible and loaded immediately (within 48 hours), early (within 6-8 weeks) or delayed (\> 8 weeks) with a provisional or definitive prosthesis. The implants will be evaluated yearly for 2 years.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Patients of either sex and at least 18 years of age.
✓. Patients for whom a decision has already been made to use a dental implant for the restoration of existing edentulism in the mandible and/or maxilla.
✓. Prior extracted sites or simultaneous extraction/implant placement.
✓. Patients must be physically able to tolerate conventional surgical and restorative procedures.
✓. Patients who provide a signed informed consent.
✓. Patients who agree to be evaluated for each study visit.

Exclusion criteria

✕. Patients who are known to be pregnant at the screening visit or planning to become pregnant within 6 months of study enrollment.
✕. Patients who have previously failed dental implants at the site intended for study implant placement.
✕. Patients with active HIV or Hepatitis infection.

What they're measuring

Dental implant integration

Timeframe: 2 years

Trial details

NCT IDNCT05062863

SponsorZimVie

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2025-10-30

View on ClinicalTrials.gov More Edentulous Jaw trials